105 related articles for article (PubMed ID: 25658377)
21. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of molecular classification of breast invasive ductal carcinoma.
Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J
Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617
[TBL] [Abstract][Full Text] [Related]
23. Folate receptor α associated with triple-negative breast cancer and poor prognosis.
Zhang Z; Wang J; Tacha DE; Li P; Bremer RE; Chen H; Wei B; Xiao X; Da J; Skinner K; Hicks DG; Bu H; Tang P
Arch Pathol Lab Med; 2014 Jul; 138(7):890-5. PubMed ID: 24028341
[TBL] [Abstract][Full Text] [Related]
24. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
Todorovic-Rakovic N; Neskovic-Konstantinovic Z
J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
[TBL] [Abstract][Full Text] [Related]
25. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
Rhee J; Han SW; Oh DY; Kim JH; Im SA; Han W; Park IA; Noh DY; Bang YJ; Kim TY
BMC Cancer; 2008 Oct; 8():307. PubMed ID: 18947390
[TBL] [Abstract][Full Text] [Related]
26. CORRELATION BETWEEN CLINICAL PATHOLOGY OF LUMINAL B BREAST CANCER AND DETERMINATION OF ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND HER2 EXPRESSION COMBINED WITH NUCLEAR MORPHOLOGY.
Yin D; Wang YL; Wang YF; Yang L; Zhang L; Tang C; Xie W; Ma Y
J Biol Regul Homeost Agents; 2015; 29(3):579-87. PubMed ID: 26403396
[TBL] [Abstract][Full Text] [Related]
27. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
[TBL] [Abstract][Full Text] [Related]
28. An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer.
McCleland ML; Adler AS; Shang Y; Hunsaker T; Truong T; Peterson D; Torres E; Li L; Haley B; Stephan JP; Belvin M; Hatzivassiliou G; Blackwood EM; Corson L; Evangelista M; Zha J; Firestein R
Cancer Res; 2012 Nov; 72(22):5812-23. PubMed ID: 23139210
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
30. A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.
Chaiwun B; Nakrungsee S; Sukhamwang N; Srisukho S
Breast Cancer; 2010; 17(1):35-41. PubMed ID: 19789946
[TBL] [Abstract][Full Text] [Related]
31. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer.
Collins LC; Marotti JD; Gelber S; Cole K; Ruddy K; Kereakoglow S; Brachtel EF; Schapira L; Come SE; Winer EP; Partridge AH
Breast Cancer Res Treat; 2012 Feb; 131(3):1061-6. PubMed ID: 22080245
[TBL] [Abstract][Full Text] [Related]
32. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
33. Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancer.
Hashimoto Y; Tatsumi S; Takeda R; Naka A; Ogane N; Kameda Y; Kawachi K; Shimizu S; Sakai M; Kamoshida S
Breast Cancer Res Treat; 2014 May; 145(1):101-11. PubMed ID: 24671357
[TBL] [Abstract][Full Text] [Related]
34. Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.
Qi JP; Yang YL; Zhu H; Wang J; Jia Y; Liu N; Song YJ; Zan LK; Zhang X; Zhou M; Gu YH; Liu T; Hicks DG; Tang P
Breast Cancer (Auckl); 2012; 6():1-8. PubMed ID: 22259247
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
Prat A; Adamo B; Cheang MC; Anders CK; Carey LA; Perou CM
Oncologist; 2013; 18(2):123-33. PubMed ID: 23404817
[TBL] [Abstract][Full Text] [Related]
36. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
[TBL] [Abstract][Full Text] [Related]
37. TYRO3 as a potential therapeutic target in breast cancer.
Ekyalongo RC; Mukohara T; Funakoshi Y; Tomioka H; Kataoka Y; Shimono Y; Chayahara N; Toyoda M; Kiyota N; Minami H
Anticancer Res; 2014 Jul; 34(7):3337-45. PubMed ID: 24982338
[TBL] [Abstract][Full Text] [Related]
38. Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs.
Willis S; De P; Dey N; Long B; Young B; Sparano JA; Wang V; Davidson NE; Leyland-Jones BR
Meta Gene; 2015 Jun; 4():129-41. PubMed ID: 26005638
[TBL] [Abstract][Full Text] [Related]
39. A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery.
Sjöström M; Ossola R; Breslin T; Rinner O; Malmström L; Schmidt A; Aebersold R; Malmström J; Niméus E
J Proteome Res; 2015 Jul; 14(7):2807-18. PubMed ID: 25944384
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological Characteristics of Triple-negative Breast Cancers in the Northeast Region of Turkey.
Yıldız B; Fidan E; Ozdemir F; Sezen O; Kavgacı H; Aydın F
Balkan Med J; 2014 Jun; 31(2):126-31. PubMed ID: 25207183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
